The pathogenesis of cardiac fibrosis (original) (raw)

• Berk BC, Fujiwara K, Lehoux S (2007) ECM remodeling in hypertensive heart disease. J Clin Invest 117:568–575
  Article CAS PubMed Central PubMed Google Scholar
• Frangogiannis NG (2012) Regulation of the inflammatory response in cardiac repair. Circ Res 110:159–173
  Article CAS PubMed Central PubMed Google Scholar
• Borer JS, Truter S, Herrold EM, Falcone DJ, Pena M, Carter JN, Dumlao TF, Lee JA, Supino PG (2002) Myocardial fibrosis in chronic aortic regurgitation: molecular and cellular responses to volume overload. Circulation 105:1837–1842
  Article CAS PubMed Google Scholar
• Ashrafian H, McKenna WJ, Watkins H (2011) Disease pathways and novel therapeutic targets in hypertrophic cardiomyopathy. Circ Res 109:86–96
  Article CAS PubMed Google Scholar
• Kania G, Blyszczuk P, Eriksson U (2009) Mechanisms of cardiac fibrosis in inflammatory heart disease. Trends Cardiovasc Med 19:247–252
  Article CAS PubMed Google Scholar
• Bernaba BN, Chan JB, Lai CK, Fishbein MC (2010) Pathology of late-onset anthracycline cardiomyopathy. Cardiovasc Pathol 19:308–311
  Article CAS PubMed Google Scholar
• Asbun J, Villarreal FJ (2006) The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy. J Am Coll Cardiol 47:693–700
  Article CAS PubMed Google Scholar
• Bharati S, Lev M (1995) Cardiac conduction system involvement in sudden death of obese young people. Am Heart J 129:273–281
  Article CAS PubMed Google Scholar
• Leonard BL, Smaill BH, LeGrice IJ (2012) Structural remodeling and mechanical function in heart failure. Microsc Microanal 18:50–67
  Article CAS PubMed Google Scholar
• Weber KT (1989) Cardiac interstitium in health and disease: the fibrillar collagen network. J Am Coll Cardiol 13:1637–1652
  Article CAS PubMed Google Scholar
• Shirwany A, Weber KT (2006) Extracellular matrix remodeling in hypertensive heart disease. J Am Coll Cardiol 48:97–98
  Article CAS PubMed Google Scholar
• Jugdutt BI (2003) Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough? Circulation 108:1395–1403
  Article PubMed Google Scholar
• Ieda M, Tsuchihashi T, Ivey KN, Ross RS, Hong TT, Shaw RM, Srivastava D (2009) Cardiac fibroblasts regulate myocardial proliferation through beta1 integrin signaling. Dev Cell 16:233–244
  Article CAS PubMed Central PubMed Google Scholar
• Eghbali M, Blumenfeld OO, Seifter S, Buttrick PM, Leinwand LA, Robinson TF, Zern MA, Giambrone MA (1989) Localization of types I, III and IV collagen mRNAs in rat heart cells by in situ hybridization. J Mol Cell Cardiol 21:103–113
  Article CAS PubMed Google Scholar
• Banerjee I, Fuseler JW, Price RL, Borg TK, Baudino TA (2007) Determination of cell types and numbers during cardiac development in the neonatal and adult rat and mouse. Am J Physiol Heart Circ Physiol 293:H1883–H1891
  Article CAS PubMed Google Scholar
• Gersch C, Dewald O, Zoerlein M, Michael LH, Entman ML, Frangogiannis NG (2002) Mast cells and macrophages in normal C57/BL/6 mice. Histochem Cell Biol 118:41–49
  CAS PubMed Google Scholar
• Brown RD, Ambler SK, Mitchell MD, Long CS (2005) The cardiac fibroblast: therapeutic target in myocardial remodeling and failure. Annu Rev Pharmacol Toxicol 45:657–687
  Article CAS PubMed Google Scholar
• Spinale FG (2007) Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. Physiol Rev 87:1285–1342
  Article CAS PubMed Google Scholar
• Janicki JS, Brower GL (2002) The role of myocardial fibrillar collagen in ventricular remodeling and function. J Card Fail 8:S319–S325
  Article CAS PubMed Google Scholar
• Iwanaga Y, Aoyama T, Kihara Y, Onozawa Y, Yoneda T, Sasayama S (2002) Excessive activation of matrix metalloproteinases coincides with left ventricular remodeling during transition from hypertrophy to heart failure in hypertensive rats. J Am Coll Cardiol 39:1384–1391
  Article CAS PubMed Google Scholar
• Baicu CF, Stroud JD, Livesay VA, Hapke E, Holder J, Spinale FG, Zile MR (2003) Changes in extracellular collagen matrix alter myocardial systolic performance. Am J Physiol Heart Circ Physiol 284:H122–H132
  CAS PubMed Google Scholar
• Wang J, Hoshijima M, Lam J, Zhou Z, Jokiel A, Dalton ND, Hultenby K, Ruiz-Lozano P, Ross J Jr, Tryggvason K, Chien KR (2006) Cardiomyopathy associated with microcirculation dysfunction in laminin alpha4 chain-deficient mice. J Biol Chem 281:213–220
  Article CAS PubMed Google Scholar
• Beltrami CA, Finato N, Rocco M, Feruglio GA, Puricelli C, Cigola E, Quaini F, Sonnenblick EH, Olivetti G, Anversa P (1994) Structural basis of end-stage failure in ischemic cardiomyopathy in humans. Circulation 89:151–163
  Article CAS PubMed Google Scholar
• Khan R, Sheppard R (2006) Fibrosis in heart disease: understanding the role of transforming growth factor-beta in cardiomyopathy, valvular disease and arrhythmia. Immunology 118:10–24
  Article CAS PubMed Google Scholar
• Hinz B (2007) Formation and function of the myofibroblast during tissue repair. J Invest Dermatol 127:526–537
  Article CAS PubMed Google Scholar
• Hinz B (2010) The myofibroblast: paradigm for a mechanically active cell. J Biomech 43:146–155
  Article PubMed Google Scholar
• Hinz B, Phan SH, Thannickal VJ, Galli A, Bochaton-Piallat ML, Gabbiani G (2007) The myofibroblast: one function, multiple origins. Am J Pathol 170:1807–1816
  Article CAS PubMed Google Scholar
• Willems IE, Havenith MG, De Mey JG, Daemen MJ (1994) The alpha-smooth muscle actin-positive cells in healing human myocardial scars. Am J Pathol 145:868–875
  CAS PubMed Google Scholar
• Leslie KO, Taatjes DJ, Schwarz J, vonTurkovich M, Low RB (1991) Cardiac myofibroblasts express alpha smooth muscle actin during right ventricular pressure overload in the rabbit. Am J Pathol 139:207–216
  CAS PubMed Google Scholar
• Wang J, Chen H, Seth A, McCulloch CA (2003) Mechanical force regulation of myofibroblast differentiation in cardiac fibroblasts. Am J Physiol Heart Circ Physiol 285:H1871–H1881
  CAS PubMed Google Scholar
• Szardien S, Nef HM, Troidl C, Willmer M, Voss S, Liebetrau C, Hoffmann J, Rolf A, Rixe J, Elsasser A et al (2012) Bone marrow-derived cells contribute to cell turnover in aging murine hearts. Int J Mol Med 30:283–287
  CAS PubMed Google Scholar
• Law BA, Levick SP, Carver WE (2012) Alterations in cardiac structure and function in a murine model of chronic alcohol consumption. Microsc Microanal 18:453–461
  Article CAS PubMed Google Scholar
• Frangogiannis NG, Perrard JL, Mendoza LH, Burns AR, Lindsey ML, Ballantyne CM, Michael LH, Smith CW, Entman ML (1998) Stem cell factor induction is associated with mast cell accumulation after canine myocardial ischemia and reperfusion. Circulation 98:687–698
  Article CAS PubMed Google Scholar
• Frangogiannis NG, Michael LH, Entman ML (2000) Myofibroblasts in reperfused myocardial infarcts express the embryonic form of smooth muscle myosin heavy chain (SMemb). Cardiovasc Res 48:89–100
  Article CAS PubMed Google Scholar
• Pichler M, Rainer PP, Schauer S, Hoefler G (2012) Cardiac fibrosis in human transplanted hearts is mainly driven by cells of intracardiac origin. J Am Coll Cardiol 59:1008–1016
  Article PubMed Google Scholar
• Frangogiannis NG, Dewald O, Xia Y, Ren G, Haudek S, Leucker T, Kraemer D, Taffet G, Rollins BJ, Entman ML (2007) Critical role of monocyte chemoattractant protein-1/CC chemokine ligand 2 in the pathogenesis of ischemic cardiomyopathy. Circulation 115:584–592
  Article CAS PubMed Google Scholar
• Haudek SB, Xia Y, Huebener P, Lee JM, Carlson S, Crawford JR, Pilling D, Gomer RH, Trial J, Frangogiannis NG, Entman ML (2006) Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice. Proc Natl Acad Sci USA 103:18284–18289
  Article CAS PubMed Google Scholar
• Mollmann H, Nef HM, Kostin S, von Kalle C, Pilz I, Weber M, Schaper J, Hamm CW, Elsasser A (2006) Bone marrow-derived cells contribute to infarct remodelling. Cardiovasc Res 71:661–671
  Article PubMed CAS Google Scholar
• Zeisberg EM, Tarnavski O, Zeisberg M, Dorfman AL, McMullen JR, Gustafsson E, Chandraker A, Yuan X, Pu WT, Roberts AB et al (2007) Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 13:952–961
  Article CAS PubMed Google Scholar
• Chu PY, Mariani J, Finch S, McMullen JR, Sadoshima J, Marshall T, Kaye DM (2010) Bone marrow-derived cells contribute to fibrosis in the chronically failing heart. Am J Pathol 176:1735–1742
  Article CAS PubMed Google Scholar
• Yano T, Miura T, Ikeda Y, Matsuda E, Saito K, Miki T, Kobayashi H, Nishino Y, Ohtani S, Shimamoto K (2005) Intracardiac fibroblasts, but not bone marrow derived cells, are the origin of myofibroblasts in myocardial infarct repair. Cardiovasc Pathol 14:241–246
  Article CAS PubMed Google Scholar
• Frangogiannis NG (2004) Chemokines in the ischemic myocardium: from inflammation to fibrosis. Inflamm Res 53:585–595
  Article CAS PubMed Google Scholar
• Frangogiannis NG (2007) Chemokines in ischemia and reperfusion. Thromb Haemost 97:738–747
  CAS PubMed Google Scholar
• Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA (2002) Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 3:349–363
  Article CAS PubMed Google Scholar
• Dobaczewski M, Gonzalez-Quesada C, Frangogiannis NG (2010) The extracellular matrix as a modulator of the inflammatory and reparative response following myocardial infarction. J Mol Cell Cardiol 48:504–511
  Article CAS PubMed Central PubMed Google Scholar
• Knowlton AA, Connelly CM, Romo GM, Mamuya W, Apstein CS, Brecher P (1992) Rapid expression of fibronectin in the rabbit heart after myocardial infarction with and without reperfusion. J Clin Invest 89:1060–1068
  Article CAS PubMed Central PubMed Google Scholar
• Arslan F, Smeets MB, Riem Vis PW, Karper JC, Quax PH, Bongartz LG, Peters JH, Hoefer IE, Doevendans PA, Pasterkamp G, de Kleijn DP (2011) Lack of fibronectin-EDA promotes survival and prevents adverse remodeling and heart function deterioration after myocardial infarction. Circ Res 108:582–592
  Article CAS PubMed Google Scholar
• Serini G, Bochaton-Piallat ML, Ropraz P, Geinoz A, Borsi L, Zardi L, Gabbiani G (1998) The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta1. J Cell Biol 142:873–881
  Article CAS PubMed Google Scholar
• Naugle JE, Olson ER, Zhang X, Mase SE, Pilati CF, Maron MB, Folkesson HG, Horne WI, Doane KJ, Meszaros JG (2006) Type VI collagen induces cardiac myofibroblast differentiation: implications for postinfarction remodeling. Am J Physiol Heart Circ Physiol 290:H323–H330
  Article CAS PubMed Google Scholar
• Carracedo S, Lu N, Popova SN, Jonsson R, Eckes B, Gullberg D (2010) The fibroblast integrin alpha11beta1 is induced in a mechanosensitive manner involving activin A and regulates myofibroblast differentiation. J Biol Chem 285:10434–10445
  Article CAS PubMed Google Scholar
• Talior-Volodarsky I, Connelly KA, Arora PD, Gullberg D, McCulloch CA (2012) α11 integrin stimulates myofibroblast differentiation in diabetic cardiomyopathy. Cardiovasc Res 96:265–275
  Article CAS PubMed Google Scholar
• Herum KM, Lunde IG, Skrbic B, Florholmen G, Behmen D, Sjaastad I, Carlson CR, Gomez MF, Christensen G (2013) Syndecan-4 signaling via NFAT regulates extracellular matrix production and cardiac myofibroblast differentiation in response to mechanical stress. J Mol Cell Cardiol 54:73–81
  Article CAS PubMed Google Scholar
• Matsui Y, Ikesue M, Danzaki K, Morimoto J, Sato M, Tanaka S, Kojima T, Tsutsui H, Uede T (2011) Syndecan-4 prevents cardiac rupture and dysfunction after myocardial infarction. Circ Res 108:1328–1339
  Article CAS PubMed Google Scholar
• Zhao XH, Laschinger C, Arora P, Szaszi K, Kapus A, McCulloch CA (2007) Force activates smooth muscle alpha-actin promoter activity through the Rho signaling pathway. J Cell Sci 120:1801–1809
  Article CAS PubMed Google Scholar
• Wynn TA, Barron L (2010) Macrophages: master regulators of inflammation and fibrosis. Semin Liver Dis 30:245–257
  Article CAS PubMed Central PubMed Google Scholar
• Frangogiannis NG, Mendoza LH, Ren G, Akrivakis S, Jackson PL, Michael LH, Smith CW, Entman ML (2003) MCSF expression is induced in healing myocardial infarcts and may regulate monocyte and endothelial cell phenotype. Am J Physiol Heart Circ Physiol 285:H483–H492
  CAS PubMed Google Scholar
• Frangogiannis NG, Shimoni S, Chang SM, Ren G, Shan K, Aggeli C, Reardon MJ, Letsou GV, Espada R, Ramchandani M et al (2002) Evidence for an active inflammatory process in the hibernating human myocardium. Am J Pathol 160:1425–1433
  Article CAS PubMed Google Scholar
• Bucala R, Spiegel LA, Chesney J, Hogan M, Cerami A (1994) Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1:71–81
  CAS PubMed Central PubMed Google Scholar
• Dewald O, Zymek P, Winkelmann K, Koerting A, Ren G, Abou-Khamis T, Michael LH, Rollins BJ, Entman ML, Frangogiannis NG (2005) CCL2/Monocyte Chemoattractant Protein-1 regulates inflammatory responses critical to healing myocardial infarcts. Circ Res 96:881–889
  Article CAS PubMed Google Scholar
• Behr TM, Wang X, Aiyar N, Coatney RW, Li X, Koster P, Angermann CE, Ohlstein E, Feuerstein GZ, Winaver J (2000) Monocyte chemoattractant protein-1 is upregulated in rats with volume-overload congestive heart failure. Circulation 102:1315–1322
  Article CAS PubMed Google Scholar
• Shao DD, Suresh R, Vakil V, Gomer RH, Pilling D (2008) Pivotal Advance: Th-1 cytokines inhibit, and Th-2 cytokines promote fibrocyte differentiation. J Leukoc Biol 83:1323–1333
  Article CAS PubMed Central PubMed Google Scholar
• Blyszczuk P, Berthonneche C, Behnke S, Glonkler M, Moch H, Pedrazzini T, Luscher TF, Eriksson U, Kania G (2013) Nitric oxide synthase 2 is required for conversion of pro-fibrogenic inflammatory CD133+ progenitors into F4/80+ macrophages in experimental autoimmune myocarditis. Cardiovasc Res 97(2):219–229
  Article CAS PubMed Google Scholar
• Nahrendorf M, Swirski FK, Aikawa E, Stangenberg L, Wurdinger T, Figueiredo JL, Libby P, Weissleder R, Pittet MJ (2007) The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med 204:3037–3047
  Article CAS PubMed Central PubMed Google Scholar
• Mantovani A, Biswas SK, Galdiero MR, Sica A, Locati M (2013) Macrophage plasticity and polarization in tissue repair and remodelling. J Pathol 229:176–185
  Article CAS PubMed Google Scholar
• Mantovani A, Sica A, Locati M (2005) Macrophage polarization comes of age. Immunity 23:344–346
  Article CAS PubMed Google Scholar
• Yang M, Zheng J, Miao Y, Wang Y, Cui W, Guo J, Qiu S, Han Y, Jia L, Li H et al (2012) Serum-glucocorticoid regulated kinase 1 regulates alternatively activated macrophage polarization contributing to angiotensin II-induced inflammation and cardiac fibrosis. Arterioscler Thromb Vasc Biol 32:1675–1686
  Article CAS PubMed Google Scholar
• Tokuda K, Kai H, Kuwahara F, Yasukawa H, Tahara N, Kudo H, Takemiya K, Koga M, Yamamoto T, Imaizumi T (2004) Pressure-independent effects of angiotensin II on hypertensive myocardial fibrosis. Hypertension 43:499–503
  Article CAS PubMed Google Scholar
• Sun Y, Zhang J, Lu L, Chen SS, Quinn MT, Weber KT (2002) Aldosterone-induced inflammation in the rat heart: role of oxidative stress. Am J Pathol 161:1773–1781
  Article CAS PubMed Google Scholar
• Rickard AJ, Morgan J, Tesch G, Funder JW, Fuller PJ, Young MJ (2009) Deletion of mineralocorticoid receptors from macrophages protects against deoxycorticosterone/salt-induced cardiac fibrosis and increased blood pressure. Hypertension 54:537–543
  Article CAS Google Scholar
• Usher MG, Duan SZ, Ivaschenko CY, Frieler RA, Berger S, Schutz G, Lumeng CN, Mortensen RM (2010) Myeloid mineralocorticoid receptor controls macrophage polarization and cardiovascular hypertrophy and remodeling in mice. J Clin Invest 120:3350–3364
  Article CAS PubMed Central PubMed Google Scholar
• Fallowfield JA, Mizuno M, Kendall TJ, Constandinou CM, Benyon RC, Duffield JS, Iredale JP (2007) Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis. J Immunol 178:5288–5295
  CAS PubMed Google Scholar
• Ramachandran P, Pellicoro A, Vernon MA, Boulter L, Aucott RL, Ali A, Hartland SN, Snowdon VK, Cappon A, Gordon-Walker TT et al (2012) Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis. Proc Natl Acad Sci USA 109:E3186–E3195
  Article CAS PubMed Google Scholar
• Levi-Schaffer F, Rubinchik E (1994) Mast cell/fibroblast interactions. Clin Exp Allergy 24:1016–1021
  Article CAS PubMed Google Scholar
• Levick SP, Melendez GC, Plante E, McLarty JL, Brower GL, Janicki JS (2012) Cardiac mast cells: the centrepiece in adverse myocardial remodelling. Cardiovasc Res 89:12–19
  Article CAS Google Scholar
• Sperr WR, Bankl HC, Mundigler G, Klappacher G, Grossschmidt K, Agis H, Simon P, Laufer P, Imhof M, Radaszkiewicz T et al (1994) The human cardiac mast cell: localization, isolation, phenotype, and functional characterization. Blood 84:3876–3884
  CAS PubMed Google Scholar
• Somasundaram P, Ren G, Nagar H, Kraemer D, Mendoza L, Michael LH, Caughey GH, Entman ML, Frangogiannis NG (2005) Mast cell tryptase may modulate endothelial cell phenotype in healing myocardial infarcts. J Pathol 205:102–111
  Article CAS PubMed Central PubMed Google Scholar
• Patella V, Marino I, Arbustini E, Lamparter-Schummert B, Verga L, Adt M, Marone G (1998) Stem cell factor in mast cells and increased mast cell density in idiopathic and ischemic cardiomyopathy. Circulation 97:971–978
  Article CAS PubMed Google Scholar
• Shiota N, Rysa J, Kovanen PT, Ruskoaho H, Kokkonen JO, Lindstedt KA (2003) A role for cardiac mast cells in the pathogenesis of hypertensive heart disease. J Hypertens 21:1935–1944
  Article CAS PubMed Google Scholar
• Wei CC, Lucchesi PA, Tallaj J, Bradley WE, Powell PC, Dell’Italia LJ (2003) Cardiac interstitial bradykinin and mast cells modulate pattern of LV remodeling in volume overload in rats. Am J Physiol Heart Circ Physiol 285:H784–H792
  CAS PubMed Google Scholar
• Hara M, Ono K, Hwang MW, Iwasaki A, Okada M, Nakatani K, Sasayama S, Matsumori A (2002) Evidence for a role of mast cells in the evolution to congestive heart failure. J Exp Med 195:375–381
  Article CAS PubMed Central PubMed Google Scholar
• Liao CH, Akazawa H, Tamagawa M, Ito K, Yasuda N, Kudo Y, Yamamoto R, Ozasa Y, Fujimoto M, Wang P et al (2010) Cardiac mast cells cause atrial fibrillation through PDGF-A-mediated fibrosis in pressure-overloaded mouse hearts. J Clin Invest 120:242–253
  Article CAS PubMed Central PubMed Google Scholar
• Levick SP, McLarty JL, Murray DB, Freeman RM, Carver WE, Brower GL (2009) Cardiac mast cells mediate left ventricular fibrosis in the hypertensive rat heart. Hypertension 53:1041–1047
  Article CAS PubMed Google Scholar
• Zhang W, Chancey AL, Tzeng HP, Zhou Z, Lavine KJ, Gao F, Sivasubramanian N, Barger PM, Mann DL (2012) The development of myocardial fibrosis in transgenic mice with targeted overexpression of tumor necrosis factor requires mast cell-fibroblast interactions. Circulation 124:2106–2116
  Article CAS Google Scholar
• Brower GL, Janicki JS (2005) Pharmacologic inhibition of mast cell degranulation prevents left ventricular remodeling induced by chronic volume overload in rats. J Card Fail 11:548–556
  Article CAS PubMed Google Scholar
• Kolck UW, Alfter K, Homann J, von Kugelgen I, Molderings GJ (2007) Cardiac mast cells: implications for heart failure. J Am Coll Cardiol 49:1107; author reply 1107–1108
  Google Scholar
• de Almeida A, Mustin D, Forman MF, Brower GL, Janicki JS, Carver W (2002) Effects of mast cells on the behavior of isolated heart fibroblasts: modulation of collagen remodeling and gene expression. J Cell Physiol 191:51–59
  Article PubMed CAS Google Scholar
• Frangogiannis NG, Lindsey ML, Michael LH, Youker KA, Bressler RB, Mendoza LH, Spengler RN, Smith CW, Entman ML (1998) Resident cardiac mast cells degranulate and release preformed TNF-alpha, initiating the cytokine cascade in experimental canine myocardial ischemia/reperfusion. Circulation 98:699–710
  Article CAS PubMed Google Scholar
• Kanellakis P, Ditiatkovski M, Kostolias G, Bobik A (2012) A pro-fibrotic role for interleukin-4 in cardiac pressure overload. Cardiovasc Res 95:77–85
  Article CAS PubMed Google Scholar
• Jordana M, Befus AD, Newhouse MT, Bienenstock J, Gauldie J (1988) Effect of histamine on proliferation of normal human adult lung fibroblasts. Thorax 43:552–558
  Article CAS PubMed Google Scholar
• Hatamochi A, Fujiwara K, Ueki H (1985) Effects of histamine on collagen synthesis by cultured fibroblasts derived from guinea pig skin. Arch Dermatol Res 277:60–64
  Article CAS PubMed Google Scholar
• Kunzmann S, Schmidt-Weber C, Zingg JM, Azzi A, Kramer BW, Blaser K, Akdis CA, Speer CP (2007) Connective tissue growth factor expression is regulated by histamine in lung fibroblasts: potential role of histamine in airway remodeling. J Allergy Clin Immunol 119:1398–1407
  Article CAS PubMed Google Scholar
• Kim J, Ogai A, Nakatani S, Hashimura K, Kanzaki H, Komamura K, Asakura M, Asanuma H, Kitamura S, Tomoike H, Kitakaze M (2006) Impact of blockade of histamine H2 receptors on chronic heart failure revealed by retrospective and prospective randomized studies. J Am Coll Cardiol 48:1378–1384
  Article CAS PubMed Google Scholar
• Urata H, Kinoshita A, Misono KS, Bumpus FM, Husain A (1990) Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. J Biol Chem 265:22348–22357
  CAS PubMed Google Scholar
• Zhao XY, Zhao LY, Zheng QS, Su JL, Guan H, Shang FJ, Niu XL, He YP, Lu XL (2008) Chymase induces profibrotic response via transforming growth factor-beta 1/Smad activation in rat cardiac fibroblasts. Mol Cell Biochem 310:159–166
  Article CAS PubMed Google Scholar
• Urata H, Healy B, Stewart RW, Bumpus FM, Husain A (1990) Angiotensin II-forming pathways in normal and failing human hearts. Circ Res 66:883–890
  Article CAS PubMed Google Scholar
• Fang KC, Raymond WW, Blount JL, Caughey GH (1997) Dog mast cell alpha-chymase activates progelatinase B by cleaving the Phe88-Gln89 and Phe91-Glu92 bonds of the catalytic domain. J Biol Chem 272:25628–25635
  Article CAS PubMed Google Scholar
• Stewart JA Jr, Wei CC, Brower GL, Rynders PE, Hankes GH, Dillon AR, Lucchesi PA, Janicki JS, Dell’Italia LJ (2003) Cardiac mast cell- and chymase-mediated matrix metalloproteinase activity and left ventricular remodeling in mitral regurgitation in the dog. J Mol Cell Cardiol 35:311–319
  Article CAS PubMed Google Scholar
• Matsumoto T, Wada A, Tsutamoto T, Ohnishi M, Isono T, Kinoshita M (2003) Chymase inhibition prevents cardiac fibrosis and improves diastolic dysfunction in the progression of heart failure. Circulation 107:2555–2558
  Article PubMed Google Scholar
• Oyamada S, Bianchi C, Takai S, Chu LM, Sellke FW (2011) Chymase inhibition reduces infarction and matrix metalloproteinase-9 activation and attenuates inflammation and fibrosis after acute myocardial ischemia/reperfusion. J Pharmacol Exp Ther 339:143–151
  Article CAS PubMed Google Scholar
• Kanemitsu H, Takai S, Tsuneyoshi H, Nishina T, Yoshikawa K, Miyazaki M, Ikeda T, Komeda M (2006) Chymase inhibition prevents cardiac fibrosis and dysfunction after myocardial infarction in rats. Hypertens Res 29:57–64
  Article CAS PubMed Google Scholar
• Ruoss SJ, Hartmann T, Caughey GH (1991) Mast cell tryptase is a mitogen for cultured fibroblasts. J Clin Invest 88:493–499
  Article CAS PubMed Central PubMed Google Scholar
• Cairns JA, Walls AF (1997) Mast cell tryptase stimulates the synthesis of type I collagen in human lung fibroblasts. J Clin Invest 99:1313–1321
  Article CAS PubMed Central PubMed Google Scholar
• McLarty JL, Melendez GC, Brower GL, Janicki JS, Levick SP (2011) Tryptase/Protease-activated receptor 2 interactions induce selective mitogen-activated protein kinase signaling and collagen synthesis by cardiac fibroblasts. Hypertension 58:264–270
  Article CAS PubMed Central PubMed Google Scholar
• Joseph J, Kennedy RH, Devi S, Wang J, Joseph L, Hauer-Jensen M (2005) Protective role of mast cells in homocysteine-induced cardiac remodeling. Am J Physiol Heart Circ Physiol 288:H2541–H2545
  Article CAS PubMed Google Scholar
• Barron L, Wynn TA (2011) Fibrosis is regulated by Th2 and Th17 responses and by dynamic interactions between fibroblasts and macrophages. Am J Physiol Gastrointest Liver Physiol 300:G723–G728
  Article CAS PubMed Google Scholar
• Chiaramonte MG, Donaldson DD, Cheever AW, Wynn TA (1999) An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response. J Clin Invest 104:777–785
  Article CAS PubMed Central PubMed Google Scholar
• Wynn TA (2011) Integrating mechanisms of pulmonary fibrosis. J Exp Med 208:1339–1350
  Article CAS PubMed Central PubMed Google Scholar
• Cieslik KA, Taffet GE, Carlson S, Hermosillo J, Trial J, Entman ML (2011) Immune-inflammatory dysregulation modulates the incidence of progressive fibrosis and diastolic stiffness in the aging heart. J Mol Cell Cardiol 50:248–256
  Article CAS PubMed Central PubMed Google Scholar
• Baldeviano GC, Barin JG, Talor MV, Srinivasan S, Bedja D, Zheng D, Gabrielson K, Iwakura Y, Rose NR, Cihakova D (2010) Interleukin-17A is dispensable for myocarditis but essential for the progression to dilated cardiomyopathy. Circ Res 106:1646–1655
  Article CAS PubMed Google Scholar
• Kanellakis P, Dinh TN, Agrotis A, Bobik A (2011) CD4(+)CD25(+)Foxp3(+) regulatory T cells suppress cardiac fibrosis in the hypertensive heart. J Hypertens 29:1820–1828
  Article CAS PubMed Google Scholar
• Kvakan H, Kleinewietfeld M, Qadri F, Park JK, Fischer R, Schwarz I, Rahn HP, Plehm R, Wellner M, Elitok S et al (2009) Regulatory T cells ameliorate angiotensin II-induced cardiac damage. Circulation 119:2904–2912
  Article CAS PubMed Google Scholar
• Tang TT, Yuan J, Zhu ZF, Zhang WC, Xiao H, Xia N, Yan XX, Nie SF, Liu J, Zhou SF et al (2012) Regulatory T cells ameliorate cardiac remodeling after myocardial infarction. Basic Res Cardiol 107:232
  Article PubMed Google Scholar
• Adiarto S, Heiden S, Vignon-Zellweger N, Nakayama K, Yagi K, Yanagisawa M, Emoto N (2012) ET-1 from endothelial cells is required for complete angiotensin II-induced cardiac fibrosis and hypertrophy. Life Sci 91:651–657
  Article CAS PubMed Google Scholar
• Widyantoro B, Emoto N, Nakayama K, Anggrahini DW, Adiarto S, Iwasa N, Yagi K, Miyagawa K, Rikitake Y, Suzuki T et al (2010) Endothelial cell-derived endothelin-1 promotes cardiac fibrosis in diabetic hearts through stimulation of endothelial-to-mesenchymal transition. Circulation 121:2407–2418
  Article CAS PubMed Google Scholar
• Frangogiannis NG, Mendoza LH, Lewallen M, Michael LH, Smith CW, Entman ML (2001) Induction and suppression of interferon-inducible protein 10 in reperfused myocardial infarcts may regulate angiogenesis. FASEB J 15:1428–1430
  CAS PubMed Google Scholar
• Bujak M, Dobaczewski M, Gonzalez-Quesada C, Xia Y, Leucker T, Zymek P, Veeranna V, Tager AM, Luster AD, Frangogiannis NG (2009) Induction of the CXC chemokine interferon-gamma-inducible protein 10 regulates the reparative response following myocardial infarction. Circ Res 105:973–983
  Article CAS PubMed Central PubMed Google Scholar
• Wei H, Bedja D, Koitabashi N, Xing D, Chen J, Fox-Talbot K, Rouf R, Chen S, Steenbergen C, Harmon JW et al (2012) Endothelial expression of hypoxia-inducible factor 1 protects the murine heart and aorta from pressure overload by suppression of TGF-beta signaling. Proc Natl Acad Sci USA 109:E841–E850
  Article CAS PubMed Google Scholar
• Frangogiannis NG (2008) The immune system and cardiac repair. Pharmacol Res 58:88–111
  Article CAS PubMed Central PubMed Google Scholar
• Dolmatova E, Spagnol G, Boassa D, Baum JR, Keith K, Ambrosi C, Kontaridis MI, Sorgen PL, Sosinsky GE, Duffy HS (2012) Cardiomyocyte ATP release through pannexin 1 aids in early fibroblast activation. Am J Physiol Heart Circ Physiol 303:H1208–H1218
  Article CAS PubMed Google Scholar
• Rickard AJ, Morgan J, Bienvenu LA, Fletcher EK, Cranston GA, Shen JZ, Reichelt ME, Delbridge LM, Young MJ (2012) Cardiomyocyte mineralocorticoid receptors are essential for deoxycorticosterone/salt-mediated inflammation and cardiac fibrosis. Hypertension 60:1443–1450
  Article CAS PubMed Google Scholar
• Koitabashi N, Danner T, Zaiman AL, Pinto YM, Rowell J, Mankowski J, Zhang D, Nakamura T, Takimoto E, Kass DA (2011) Pivotal role of cardiomyocyte TGF-beta signaling in the murine pathological response to sustained pressure overload. J Clin Invest 121:2301–2312
  Article CAS PubMed Central PubMed Google Scholar
• Kurisu S, Ozono R, Oshima T, Kambe M, Ishida T, Sugino H, Matsuura H, Chayama K, Teranishi Y, Iba O et al (2003) Cardiac angiotensin II type 2 receptor activates the kinin/NO system and inhibits fibrosis. Hypertension 41:99–107
  Article CAS PubMed Google Scholar
• Cleutjens JP, Verluyten MJ, Smiths JF, Daemen MJ (1995) Collagen remodeling after myocardial infarction in the rat heart. Am J Pathol 147:325–338
  CAS PubMed Google Scholar
• Mukherjee D, Sen S (1993) Alteration of cardiac collagen phenotypes in hypertensive hypertrophy: role of blood pressure. J Mol Cell Cardiol 25:185–196
  Article CAS PubMed Google Scholar
• Whittaker P, Boughner DR, Kloner RA (1989) Analysis of healing after myocardial infarction using polarized light microscopy. Am J Pathol 134:879–893
  CAS PubMed Google Scholar
• Mukherjee D, Sen S (1991) Alteration of collagen phenotypes in ischemic cardiomyopathy. J Clin Invest 88:1141–1146
  Article CAS PubMed Central PubMed Google Scholar
• Lopez B, Querejeta R, Gonzalez A, Larman M, Diez J (2012) Collagen cross-linking but not collagen amount associates with elevated filling pressures in hypertensive patients with stage C heart failure: potential role of lysyl oxidase. Hypertension 60:677–683
  Article CAS PubMed Google Scholar
• Woodiwiss AJ, Tsotetsi OJ, Sprott S, Lancaster EJ, Mela T, Chung ES, Meyer TE, Norton GR (2001) Reduction in myocardial collagen cross-linking parallels left ventricular dilatation in rat models of systolic chamber dysfunction. Circulation 103:155–160
  Article CAS PubMed Google Scholar
• Frangogiannis NG (2012) Matricellular proteins in cardiac adaptation and disease. Physiol Rev 92:635–688
  Article CAS PubMed Google Scholar
• Luther DJ, Thodeti CK, Shamhart PE, Adapala RK, Hodnichak C, Weihrauch D, Bonaldo P, Chilian WM, Meszaros JG (2012) Absence of type VI collagen paradoxically improves cardiac function, structure, and remodeling after myocardial infarction. Circ Res 110:851–856
  Article CAS PubMed Google Scholar
• Dobaczewski M, Bujak M, Zymek P, Ren G, Entman ML, Frangogiannis NG (2006) Extracellular matrix remodeling in canine and mouse myocardial infarcts. Cell Tissue Res 324:475–488
  Article CAS PubMed Google Scholar
• Rybarczyk BJ, Lawrence SO, Simpson-Haidaris PJ (2003) Matrix-fibrinogen enhances wound closure by increasing both cell proliferation and migration. Blood 102:4035–4043
  Article CAS PubMed Google Scholar
• Greiling D, Clark RA (1997) Fibronectin provides a conduit for fibroblast transmigration from collagenous stroma into fibrin clot provisional matrix. J Cell Sci 110(Pt 7):861–870
  CAS PubMed Google Scholar
• Lin F, Ren XD, Doris G, Clark RA (2005) Three-dimensional migration of human adult dermal fibroblasts from collagen lattices into fibrin/fibronectin gels requires syndecan-4 proteoglycan. J Invest Dermatol 124:906–913
  Article CAS PubMed Google Scholar
• Welch MP, Odland GF, Clark RA (1990) Temporal relationships of F-actin bundle formation, collagen and fibronectin matrix assembly, and fibronectin receptor expression to wound contraction. J Cell Biol 110:133–145
  Article CAS PubMed Google Scholar
• Samuel JL, Barrieux A, Dufour S, Dubus I, Contard F, Koteliansky V, Farhadian F, Marotte F, Thiery JP, Rappaport L (1991) Accumulation of fetal fibronectin mRNAs during the development of rat cardiac hypertrophy induced by pressure overload. J Clin Invest 88:1737–1746
  Article CAS PubMed Central PubMed Google Scholar
• Villarreal FJ, Dillmann WH (1992) Cardiac hypertrophy-induced changes in mRNA levels for TGF-beta 1, fibronectin, and collagen. Am J Physiol 262:H1861–H1866
  CAS PubMed Google Scholar
• Franz M, Grun K, Richter P, Brehm BR, Fritzenwanger M, Hekmat K, Neri D, Gummert J, Figulla HR, Kosmehl H et al (2010) Extra cellular matrix remodelling after heterotopic rat heart transplantation: gene expression profiling and involvement of ED-A+ fibronectin, alpha-smooth muscle actin and B+ tenascin-C in chronic cardiac allograft rejection. Histochem Cell Biol 134:503–517
  Article CAS PubMed Google Scholar
• Santiago JJ, Dangerfield AL, Rattan SG, Bathe KL, Cunnington RH, Raizman JE, Bedosky KM, Freed DH, Kardami E, Dixon IM (2010) Cardiac fibroblast to myofibroblast differentiation in vivo and in vitro: expression of focal adhesion components in neonatal and adult rat ventricular myofibroblasts. Dev Dyn 239:1573–1584
  Article CAS PubMed Google Scholar
• Bornstein P (2009) Matricellular proteins: an overview. J Cell Commun Signal 3:163–165
  Article PubMed Central PubMed Google Scholar
• Xia Y, Dobaczewski M, Gonzalez-Quesada C, Chen W, Biernacka A, Li N, Lee DW, Frangogiannis NG (2011) Endogenous thrombospondin 1 protects the pressure-overloaded myocardium by modulating fibroblast phenotype and matrix metabolism. Hypertension 58:902–911
  Article CAS PubMed Central PubMed Google Scholar
• Swinnen M, Vanhoutte D, Van Almen GC, Hamdani N, Schellings MW, D’Hooge J, Van der Velden J, Weaver MS, Sage EH, Bornstein P et al (2009) Absence of thrombospondin-2 causes age-related dilated cardiomyopathy. Circulation 120:1585–1597
  Article CAS PubMed Google Scholar
• Frolova EG, Sopko N, Blech L, Popovic ZB, Li J, Vasanji A, Drumm C, Krukovets I, Jain MK, Penn MS et al (2012) Thrombospondin-4 regulates fibrosis and remodeling of the myocardium in response to pressure overload. FASEB J 26:2363–2373
  Article CAS PubMed Google Scholar
• Adams JC, Lawler J (2004) The thrombospondins. Int J Biochem Cell Biol 36:961–968
  Article CAS PubMed Central PubMed Google Scholar
• Frangogiannis NG, Ren G, Dewald O, Zymek P, Haudek S, Koerting A, Winkelmann K, Michael LH, Lawler J, Entman ML (2005) The critical role of endogenous thrombospondin (TSP)-1 in preventing expansion of healing myocardial infarcts. Circulation 111:2935–2942
  Article CAS PubMed Google Scholar
• Rodriguez-Manzaneque JC, Lane TF, Ortega MA, Hynes RO, Lawler J, Iruela-Arispe ML (2001) Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor. Proc Natl Acad Sci USA 98:12485–12490
  Article CAS PubMed Google Scholar
• Hogg PJ (1994) Thrombospondin 1 as an enzyme inhibitor. Thromb Haemost 72:787–792
  CAS PubMed Google Scholar
• Schroen B, Heymans S, Sharma U, Blankesteijn WM, Pokharel S, Cleutjens JP, Porter JG, Evelo CT, Duisters R, van Leeuwen RE et al (2004) Thrombospondin-2 is essential for myocardial matrix integrity: increased expression identifies failure-prone cardiac hypertrophy. Circ Res 95:515–522
  Article CAS PubMed Google Scholar
• Cingolani OH, Kirk JA, Seo K, Koitabashi N, Lee DI, Ramirez-Correa G, Bedja D, Barth AS, Moens AL, Kass DA (2011) Thrombospondin-4 is required for stretch-mediated contractility augmentation in cardiac muscle. Circ Res 109:1410–1414
  Article CAS PubMed Central PubMed Google Scholar
• Chablais F, Jazwinska A (2012) The regenerative capacity of the zebrafish heart is dependent on TGFbeta signaling. Development 139:1921–1930
  Article CAS PubMed Google Scholar
• Imanaka-Yoshida K, Hiroe M, Yoshida T (2004) Interaction between cell and extracellular matrix in heart disease: multiple roles of tenascin-C in tissue remodeling. Histol Histopathol 19:517–525
  CAS PubMed Google Scholar
• Frangogiannis NG, Shimoni S, Chang SM, Ren G, Dewald O, Gersch C, Shan K, Aggeli C, Reardon M, Letsou GV et al (2002) Active interstitial remodeling: an important process in the hibernating human myocardium. J Am Coll Cardiol 39:1468–1474
  Article PubMed Google Scholar
• Willems IE, Arends JW, Daemen MJ (1996) Tenascin and fibronectin expression in healing human myocardial scars. J Pathol 179:321–325
  Article CAS PubMed Google Scholar
• Tamaoki M, Imanaka-Yoshida K, Yokoyama K, Nishioka T, Inada H, Hiroe M, Sakakura T, Yoshida T (2005) Tenascin-C regulates recruitment of myofibroblasts during tissue repair after myocardial injury. Am J Pathol 167:71–80
  Article CAS PubMed Google Scholar
• Nishioka T, Onishi K, Shimojo N, Nagano Y, Matsusaka H, Ikeuchi M, Ide T, Tsutsui H, Hiroe M, Yoshida T, Imanaka-Yoshida K (2010) Tenascin-C may aggravate left ventricular remodeling and function after myocardial infarction in mice. Am J Physiol Heart Circ Physiol 298:H1072–H1078
  Article CAS PubMed Google Scholar
• Schellings MW, Vanhoutte D, Swinnen M, Cleutjens JP, Debets J, van Leeuwen RE, d’Hooge J, Van de Werf F, Carmeliet P, Pinto YM et al (2009) Absence of SPARC results in increased cardiac rupture and dysfunction after acute myocardial infarction. J Exp Med 206:113–123
  Article CAS PubMed Central PubMed Google Scholar
• Murry CE, Giachelli CM, Schwartz SM, Vracko R (1994) Macrophages express osteopontin during repair of myocardial necrosis. Am J Pathol 145:1450–1462
  CAS PubMed Google Scholar
• Trueblood NA, Xie Z, Communal C, Sam F, Ngoy S, Liaw L, Jenkins AW, Wang J, Sawyer DB, Bing OH et al (2001) Exaggerated left ventricular dilation and reduced collagen deposition after myocardial infarction in mice lacking osteopontin. Circ Res 88:1080–1087
  Article CAS PubMed Google Scholar
• Sam F, Xie Z, Ooi H, Kerstetter DL, Colucci WS, Singh M, Singh K (2004) Mice lacking osteopontin exhibit increased left ventricular dilation and reduced fibrosis after aldosterone infusion. Am J Hypertens 17:188–193
  Article CAS PubMed Google Scholar
• Collins AR, Schnee J, Wang W, Kim S, Fishbein MC, Bruemmer D, Law RE, Nicholas S, Ross RS, Hsueh WA (2004) Osteopontin modulates angiotensin II-induced fibrosis in the intact murine heart. J Am Coll Cardiol 43:1698–1705
  Article CAS PubMed Google Scholar
• Psarras S, Mavroidis M, Sanoudou D, Davos CH, Xanthou G, Varela AE, Panoutsakopoulou V, Capetanaki Y (2012) Regulation of adverse remodelling by osteopontin in a genetic heart failure model. Eur Heart J 33:1954–1963
  Article CAS PubMed Google Scholar
• Xie Z, Singh M, Singh K (2004) Osteopontin modulates myocardial hypertrophy in response to chronic pressure overload in mice. Hypertension 44:826–831
  Article CAS PubMed Google Scholar
• Zohar R, Zhu B, Liu P, Sodek J, McCulloch CA (2004) Increased cell death in osteopontin-deficient cardiac fibroblasts occurs by a caspase-3-independent pathway. Am J Physiol Heart Circ Physiol 287:H1730–H1739
  Article CAS PubMed Google Scholar
• Oka T, Xu J, Kaiser RA, Melendez J, Hambleton M, Sargent MA, Lorts A, Brunskill EW, Dorn GW 2nd, Conway SJ et al (2007) Genetic manipulation of periostin expression reveals a role in cardiac hypertrophy and ventricular remodeling. Circ Res 101:313–321
  Article CAS PubMed Central PubMed Google Scholar
• Shimazaki M, Nakamura K, Kii I, Kashima T, Amizuka N, Li M, Saito M, Fukuda K, Nishiyama T, Kitajima S et al (2008) Periostin is essential for cardiac healing after acute myocardial infarction. J Exp Med 205:295–303
  Article CAS PubMed Central PubMed Google Scholar
• Leask A (2010) Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation. Circ Res 106:1675–1680
  Article CAS PubMed Google Scholar
• Ahmed MS, Gravning J, Martinov VN, von Lueder TG, Edvardsen T, Czibik G, Moe IT, Vinge LE, Oie E, Valen G, Attramadal H (2011) Mechanisms of novel cardioprotective functions of CCN2/CTGF in myocardial ischemia/reperfusion injury. Am J Physiol Heart Circ Physiol 300(4):H1291–H1302
  Article CAS PubMed Google Scholar
• Teufel A, Becker D, Weber SN, Dooley S, Breitkopf-Heinlein K, Maass T, Hochrath K, Krupp M, Marquardt JU, Kolb M et al (2012) Identification of RARRES1 as a core regulator in liver fibrosis. J Mol Med (Berl) 90:1439–1447
  Article CAS Google Scholar
• Mehal WZ, Iredale J, Friedman SL (2011) Scraping fibrosis: expressway to the core of fibrosis. Nat Med 17:552–553
  Article CAS PubMed Central PubMed Google Scholar
• Siwik DA, Pagano PJ, Colucci WS (2001) Oxidative stress regulates collagen synthesis and matrix metalloproteinase activity in cardiac fibroblasts. Am J Physiol Cell Physiol 280:C53–C60
  CAS PubMed Google Scholar
• Barcellos-Hoff MH, Dix TA (1996) Redox-mediated activation of latent transforming growth factor-beta 1. Mol Endocrinol 10:1077–1083
  CAS PubMed Google Scholar
• Cheng TH, Cheng PY, Shih NL, Chen IB, Wang DL, Chen JJ (2003) Involvement of reactive oxygen species in angiotensin II-induced endothelin-1 gene expression in rat cardiac fibroblasts. J Am Coll Cardiol 42:1845–1854
  Article CAS PubMed Google Scholar
• Siwik DA, Colucci WS (2004) Regulation of matrix metalloproteinases by cytokines and reactive oxygen/nitrogen species in the myocardium. Heart Fail Rev 9:43–51
  Article CAS PubMed Google Scholar
• Ohtsu H, Frank GD, Utsunomiya H, Eguchi S (2005) Redox-dependent protein kinase regulation by angiotensin II: mechanistic insights and its pathophysiology. Antioxid Redox Signal 7:1315–1326
  Article CAS PubMed Google Scholar
• Lijnen P, Papparella I, Petrov V, Semplicini A, Fagard R (2006) Angiotensin II-stimulated collagen production in cardiac fibroblasts is mediated by reactive oxygen species. J Hypertens 24:757–766
  Article CAS PubMed Google Scholar
• Dai DF, Johnson SC, Villarin JJ, Chin MT, Nieves-Cintron M, Chen T, Marcinek DJ, Dorn GW 2nd, Kang YJ, Prolla TA et al (2011) Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and Galphaq overexpression-induced heart failure. Circ Res 108:837–846
  Article CAS PubMed Central PubMed Google Scholar
• Dewald O, Frangogiannis NG, Zoerlein M, Duerr GD, Klemm C, Knuefermann P, Taffet G, Michael LH, Crapo JD, Welz A, Entman ML (2003) Development of murine ischemic cardiomyopathy is associated with a transient inflammatory reaction and depends on reactive oxygen species. Proc Natl Acad Sci USA 100:2700–2705
  Article CAS PubMed Google Scholar
• Iglarz M, Touyz RM, Viel EC, Amiri F, Schiffrin EL (2004) Involvement of oxidative stress in the profibrotic action of aldosterone. Interaction wtih the renin-angiotension system. Am J Hypertens 17:597–603
  CAS PubMed Google Scholar
• Rollins BJ (1997) Chemokines. Blood 90:909–928
  CAS PubMed Google Scholar
• Dobaczewski M, Frangogiannis NG (2009) Chemokines and cardiac fibrosis. Front Biosci (Schol Ed) 1:391–405
  Google Scholar
• Xia Y, Frangogiannis NG (2007) MCP-1/CCL2 as a therapeutic target in myocardial infarction and ischemic cardiomyopathy. Inflamm Allergy Drug Targets 6:101–107
  Article CAS PubMed Google Scholar
• Kuwahara F, Kai H, Tokuda K, Takeya M, Takeshita A, Egashira K, Imaizumi T (2004) Hypertensive myocardial fibrosis and diastolic dysfunction: another model of inflammation? Hypertension 43:739–745
  Article CAS PubMed Google Scholar
• Sakai N, Wada T, Furuichi K, Shimizu K, Kokubo S, Hara A, Yamahana J, Okumura T, Matsushima K, Yokoyama H, Kaneko S (2006) MCP-1/CCR2-dependent loop for fibrogenesis in human peripheral CD14-positive monocytes. J Leukoc Biol 79:555–563
  Article CAS PubMed Google Scholar
• Kruglov EA, Nathanson RA, Nguyen T, Dranoff JA (2006) Secretion of MCP-1/CCL2 by bile duct epithelia induces myofibroblastic transdifferentiation of portal fibroblasts. Am J Physiol Gastrointest Liver Physiol 290:G765–G771
  Article CAS PubMed Google Scholar
• Gharaee-Kermani M, Denholm EM, Phan SH (1996) Costimulation of fibroblast collagen and transforming growth factor beta1 gene expression by monocyte chemoattractant protein-1 via specific receptors. J Biol Chem 271:17779–17784
  Article CAS PubMed Google Scholar
• Yamamoto T, Eckes B, Mauch C, Hartmann K, Krieg T (2000) Monocyte chemoattractant protein-1 enhances gene expression and synthesis of matrix metalloproteinase-1 in human fibroblasts by an autocrine IL-1 alpha loop. J Immunol 164:6174–6179
  CAS PubMed Google Scholar
• Quan TE, Cowper S, Wu SP, Bockenstedt LK, Bucala R (2004) Circulating fibrocytes: collagen-secreting cells of the peripheral blood. Int J Biochem Cell Biol 36:598–606
  Article CAS PubMed Google Scholar
• Moore BB, Kolodsick JE, Thannickal VJ, Cooke K, Moore TA, Hogaboam C, Wilke CA, Toews GB (2005) CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury. Am J Pathol 166:675–684
  Article CAS PubMed Google Scholar
• Haudek SB, Cheng J, Du J, Wang Y, Hermosillo-Rodriguez J, Trial J, Taffet GE, Entman ML (2010) Monocytic fibroblast precursors mediate fibrosis in angiotensin-II-induced cardiac hypertrophy. J Mol Cell Cardiol 49:499–507
  Article CAS PubMed Central PubMed Google Scholar
• Torre-Amione G, Kapadia S, Lee J, Durand JB, Bies RD, Young JB, Mann DL (1996) Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. Circulation 93:704–711
  Article CAS PubMed Google Scholar
• Habib FM, Springall DR, Davies GJ, Oakley CM, Yacoub MH, Polak JM (1996) Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy. Lancet 347:1151–1155
  Article CAS PubMed Google Scholar
• Francis SE, Holden H, Holt CM, Duff GW (1998) Interleukin-1 in myocardium and coronary arteries of patients with dilated cardiomyopathy. J Mol Cell Cardiol 30:215–223
  Article CAS PubMed Google Scholar
• Plenz G, Song ZF, Reichenberg S, Tjan TD, Robenek H, Deng MC (1998) Left-ventricular expression of interleukin-6 messenger-RNA higher in idiopathic dilated than in ischemic cardiomyopathy. Thorac Cardiovasc Surg 46:213–216
  Article CAS PubMed Google Scholar
• Timonen P, Magga J, Risteli J, Punnonen K, Vanninen E, Turpeinen A, Tuomainen P, Kuusisto J, Vuolteenaho O, Peuhkurinen K (2008) Cytokines, interstitial collagen and ventricular remodelling in dilated cardiomyopathy. Int J Cardiol 124:293–300
  Article PubMed Google Scholar
• Bujak M, Dobaczewski M, Chatila K, Mendoza LH, Li N, Reddy A, Frangogiannis NG (2008) Interleukin-1 receptor type I signaling critically regulates infarct healing and cardiac remodeling. Am J Pathol 173:57–67
  Article PubMed Google Scholar
• Li J, Schwimmbeck PL, Tschope C, Leschka S, Husmann L, Rutschow S, Reichenbach F, Noutsias M, Kobalz U, Poller W et al (2002) Collagen degradation in a murine myocarditis model: relevance of matrix metalloproteinase in association with inflammatory induction. Cardiovasc Res 56:235–247
  Article CAS PubMed Google Scholar
• Siwik DA, Chang DL, Colucci WS (2000) Interleukin-1beta and tumor necrosis factor-alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro. Circ Res 86:1259–1265
  Article CAS PubMed Google Scholar
• Mitchell MD, Laird RE, Brown RD, Long CS (2007) IL-1beta stimulates rat cardiac fibroblast migration via MAP kinase pathways. Am J Physiol Heart Circ Physiol 292:H1139–H1147
  Article CAS PubMed Google Scholar
• Palmer JN, Hartogensis WE, Patten M, Fortuin FD, Long CS (1995) Interleukin-1 beta induces cardiac myocyte growth but inhibits cardiac fibroblast proliferation in culture. J Clin Invest 95:2555–2564
  Article CAS PubMed Central PubMed Google Scholar
• Koudssi F, Lopez JE, Villegas S, Long CS (1998) Cardiac fibroblasts arrest at the G1/S restriction point in response to interleukin (IL)-1beta. Evidence for IL-1beta-induced hypophosphorylation of the retinoblastoma protein. J Biol Chem 273:25796–25803
  Article CAS PubMed Google Scholar
• Kacimi R, Vessey DA, Honbo N, Karliner JS (2007) Adult cardiac fibroblasts null for sphingosine kinase-1 exhibit growth dysregulation and an enhanced proinflammatory response. J Mol Cell Cardiol 43:85–91
  Article CAS PubMed Google Scholar
• Bryant D, Becker L, Richardson J, Shelton J, Franco F, Peshock R, Thompson M, Giroir B (1998) Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha. Circulation 97:1375–1381
  Article CAS PubMed Google Scholar
• Li YY, Feng YQ, Kadokami T, McTiernan CF, Draviam R, Watkins SC, Feldman AM (2000) Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy. Proc Natl Acad Sci USA 97:12746–12751
  Article CAS PubMed Google Scholar
• Sivasubramanian N, Coker ML, Kurrelmeyer KM, MacLellan WR, DeMayo FJ, Spinale FG, Mann DL (2001) Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor. Circulation 104:826–831
  Article CAS PubMed Google Scholar
• Zhang W, Chancey AL, Tzeng HP, Zhou Z, Lavine KJ, Gao F, Sivasubramanian N, Barger PM, Mann DL (2011) The development of myocardial fibrosis in transgenic mice with targeted overexpression of tumor necrosis factor requires mast cell-fibroblast interactions. Circulation 124:2106–2116
  Article CAS PubMed Central PubMed Google Scholar
• Sun M, Chen M, Dawood F, Zurawska U, Li JY, Parker T, Kassiri Z, Kirshenbaum LA, Arnold M, Khokha R, Liu PP (2007) Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state. Circulation 115:1398–1407
  Article CAS PubMed Google Scholar
• Duerrschmid C, Crawford JR, Reineke E, Taffet GE, Trial J, Entman ML, Haudek SB (2013) TNF receptor 1 signaling is critically involved in mediating angiotensin-II-induced cardiac fibrosis. J Mol Cell Cardiol 57:59–67
  Article CAS PubMed Google Scholar
• Hamid T, Gu Y, Ortines RV, Bhattacharya C, Wang G, Xuan YT, Prabhu SD (2009) Divergent tumor necrosis factor receptor-related remodeling responses in heart failure: role of nuclear factor-kappaB and inflammatory activation. Circulation 119:1386–1397
  Article CAS PubMed Central PubMed Google Scholar
• Weber KT, Sun Y, Bhattacharya SK, Ahokas RA, Gerling IC (2012) Myofibroblast-mediated mechanisms of pathological remodelling of the heart. Nat Rev Cardiol 10:15–26
  Article PubMed CAS Google Scholar
• Schorb W, Booz GW, Dostal DE, Conrad KM, Chang KC, Baker KM (1993) Angiotensin II is mitogenic in neonatal rat cardiac fibroblasts. Circ Res 72:1245–1254
  Article CAS PubMed Google Scholar
• Sadoshima J, Izumo S (1993) Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype. Circ Res 73:413–423
  Article CAS PubMed Google Scholar
• Crabos M, Roth M, Hahn AW, Erne P (1994) Characterization of angiotensin II receptors in cultured adult rat cardiac fibroblasts. Coupling to signaling systems and gene expression. J Clin Invest 93:2372–2378
  Article CAS PubMed Central PubMed Google Scholar
• Ohkubo N, Matsubara H, Nozawa Y, Mori Y, Murasawa S, Kijima K, Maruyama K, Masaki H, Tsutumi Y, Shibazaki Y et al (1997) Angiotensin type 2 receptors are reexpressed by cardiac fibroblasts from failing myopathic hamster hearts and inhibit cell growth and fibrillar collagen metabolism. Circulation 96:3954–3962
  Article CAS PubMed Google Scholar
• Schieffer B, Wirger A, Meybrunn M, Seitz S, Holtz J, Riede UN, Drexler H (1994) Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat. Circulation 89:2273–2282
  Article CAS PubMed Google Scholar
• Regan CP, Anderson PG, Bishop SP, Berecek KH (1997) Pressure-independent effects of AT1-receptor antagonism on cardiovascular remodeling in aortic-banded rats. Am J Physiol 272:H2131–H2138
  CAS PubMed Google Scholar
• Lijnen P, Petrov V (2000) Induction of cardiac fibrosis by aldosterone. J Mol Cell Cardiol 32:865–879
  Article CAS PubMed Google Scholar
• Campbell SE, Diaz-Arias AA, Weber KT (1992) Fibrosis of the human heart and systemic organs in adrenal adenoma. Blood Press 1:149–156
  Article CAS PubMed Google Scholar
• Neumann S, Huse K, Semrau R, Diegeler A, Gebhardt R, Buniatian GH, Scholz GH (2002) Aldosterone and d-glucose stimulate the proliferation of human cardiac myofibroblasts in vitro. Hypertension 39:756–760
  Article CAS PubMed Google Scholar
• Brilla CG, Zhou G, Matsubara L, Weber KT (1994) Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone. J Mol Cell Cardiol 26:809–820
  Article CAS PubMed Google Scholar
• Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341:709–717
  Article CAS PubMed Google Scholar
• Biernacka A, Dobaczewski M, Frangogiannis NG (2011) TGF-beta signaling in fibrosis. Growth Factors 29:196–202
  Article CAS PubMed Google Scholar
• Dobaczewski M, Chen W, Frangogiannis NG (2011) Transforming growth factor (TGF)-beta signaling in cardiac remodeling. J Mol Cell Cardiol 51:600–606
  Article CAS PubMed Central PubMed Google Scholar
• Pauschinger M, Knopf D, Petschauer S, Doerner A, Poller W, Schwimmbeck PL, Kuhl U, Schultheiss HP (1999) Dilated cardiomyopathy is associated with significant changes in collagen type I/III ratio. Circulation 99:2750–2756
  Article CAS PubMed Google Scholar
• Li RK, Li G, Mickle DA, Weisel RD, Merante F, Luss H, Rao V, Christakis GT, Williams WG (1997) Overexpression of transforming growth factor-beta1 and insulin-like growth factor-I in patients with idiopathic hypertrophic cardiomyopathy. Circulation 96:874–881
  Article CAS PubMed Google Scholar
• Schiller M, Javelaud D, Mauviel A (2004) TGF-beta-induced SMAD signaling and gene regulation: consequences for extracellular matrix remodeling and wound healing. J Dermatol Sci 35:83–92
  Article CAS PubMed Google Scholar
• Annes JP, Munger JS, Rifkin DB (2003) Making sense of latent TGFbeta activation. J Cell Sci 116:217–224
  Article CAS PubMed Google Scholar
• Ignotz RA, Massague J (1986) Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 261:4337–4345
  CAS PubMed Google Scholar
• Rifkin DB, Mazzieri R, Munger JS, Noguera I, Sung J (1999) Proteolytic control of growth factor availability. APMIS 107:80–85
  Article CAS PubMed Google Scholar
• Barcellos-Hoff MH, Derynck R, Tsang ML, Weatherbee JA (1994) Transforming growth factor-beta activation in irradiated murine mammary gland. J Clin Invest 93:892–899
  Article CAS PubMed Central PubMed Google Scholar
• Lyons RM, Keski-Oja J, Moses HL (1988) Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium. J Cell Biol 106:1659–1665
  Article CAS PubMed Google Scholar
• Seeland U, Haeuseler C, Hinrichs R, Rosenkranz S, Pfitzner T, Scharffetter-Kochanek K, Bohm M (2002) Myocardial fibrosis in transforming growth factor-beta(1) (TGF-beta(1)) transgenic mice is associated with inhibition of interstitial collagenase. Eur J Clin Invest 32:295–303
  Article CAS PubMed Google Scholar
• Rosenkranz S, Flesch M, Amann K, Haeuseler C, Kilter H, Seeland U, Schluter KD, Bohm M (2002) Alterations of beta-adrenergic signaling and cardiac hypertrophy in transgenic mice overexpressing TGF-beta(1). Am J Physiol Heart Circ Physiol 283:H1253–H1262
  CAS PubMed Google Scholar
• Nakajima H, Nakajima HO, Salcher O, Dittie AS, Dembowsky K, Jing S, Field LJ (2000) Atrial but not ventricular fibrosis in mice expressing a mutant transforming growth factor-beta(1) transgene in the heart. Circ Res 86:571–579
  Article CAS PubMed Google Scholar
• Brooks WW, Conrad CH (2000) Myocardial fibrosis in transforming growth factor beta(1)heterozygous mice. J Mol Cell Cardiol 32:187–195
  Article CAS PubMed Google Scholar
• Kuwahara F, Kai H, Tokuda K, Kai M, Takeshita A, Egashira K, Imaizumi T (2002) Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats. Circulation 106:130–135
  Article CAS PubMed Google Scholar
• Leask A, Abraham DJ (2004) TGF-beta signaling and the fibrotic response. FASEB J 18:816–827
  Article CAS PubMed Google Scholar
• Desmouliere A, Geinoz A, Gabbiani F, Gabbiani G (1993) Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 122:103–111
  Article CAS PubMed Google Scholar
• Mori T, Kawara S, Shinozaki M, Hayashi N, Kakinuma T, Igarashi A, Takigawa M, Nakanishi T, Takehara K (1999) Role and interaction of connective tissue growth factor with transforming growth factor-beta in persistent fibrosis: a mouse fibrosis model. J Cell Physiol 181:153–159
  Article CAS PubMed Google Scholar
• Bujak M, Ren G, Kweon HJ, Dobaczewski M, Reddy A, Taffet G, Wang XF, Frangogiannis NG (2007) Essential role of Smad3 in infarct healing and in the pathogenesis of cardiac remodeling. Circulation 116:2127–2138
  Article CAS PubMed Google Scholar
• Kapur NK, Wilson S, Yunis AA, Qiao X, Mackey E, Paruchuri V, Baker C, Aronovitz MJ, Karumanchi SA, Letarte M et al (2012) Reduced endoglin activity limits cardiac fibrosis and improves survival in heart failure. Circulation 125:2728–2738
  Article CAS PubMed Google Scholar
• Villar AV, Garcia R, Llano M, Cobo M, Merino D, Lantero A, Tramullas M, Hurle JM, Hurle MA, Nistal JF (2013) BAMBI (BMP and activin membrane-bound inhibitor) protects the murine heart from pressure-overload biomechanical stress by restraining TGF-beta signaling. Biochim Biophys Acta 1832:323–335
  Article CAS PubMed Google Scholar
• Itoh S, ten Dijke P (2007) Negative regulation of TGF-beta receptor/Smad signal transduction. Curr Opin Cell Biol 19:176–184
  Article CAS PubMed Google Scholar
• Alvarez D, Briassouli P, Clancy RM, Zavadil J, Reed JH, Abellar RG, Halushka M, Fox-Talbot K, Barrat FJ, Buyon JP (2011) A novel role of endothelin-1 in linking Toll-like receptor 7-mediated inflammation to fibrosis in congenital heart block. J Biol Chem 286:30444–30454
  Article CAS PubMed Google Scholar
• Shi-wen X, Kennedy L, Renzoni EA, Bou-Gharios G, du Bois RM, Black CM, Denton CP, Abraham DJ, Leask A (2007) Endothelin is a downstream mediator of profibrotic responses to transforming growth factor beta in human lung fibroblasts. Arthritis Rheum 56:4189–4194
  Article PubMed CAS Google Scholar
• Tsutamoto T, Wada A, Maeda K, Mabuchi N, Hayashi M, Tsutsui T, Ohnishi M, Sawaki M, Fujii M, Matsumoto T et al (2000) Transcardiac extraction of circulating endothelin-1 across the failing heart. Am J Cardiol 86:524–528
  Article CAS PubMed Google Scholar
• Yamamoto K, Masuyama T, Sakata Y, Mano T, Nishikawa N, Kondo H, Akehi N, Kuzuya T, Miwa T, Hori M (2000) Roles of renin-angiotensin and endothelin systems in development of diastolic heart failure in hypertensive hearts. Cardiovasc Res 47:274–283
  Article CAS PubMed Google Scholar
• Piacentini L, Gray M, Honbo NY, Chentoufi J, Bergman M, Karliner JS (2000) Endothelin-1 stimulates cardiac fibroblast proliferation through activation of protein kinase C. J Mol Cell Cardiol 32:565–576
  Article CAS PubMed Google Scholar
• Guarda E, Katwa LC, Myers PR, Tyagi SC, Weber KT (1993) Effects of endothelins on collagen turnover in cardiac fibroblasts. Cardiovasc Res 27:2130–2134
  Article CAS PubMed Google Scholar
• Kulasekaran P, Scavone CA, Rogers DS, Arenberg DA, Thannickal VJ, Horowitz JC (2009) Endothelin-1 and transforming growth factor-beta1 independently induce fibroblast resistance to apoptosis via AKT activation. Am J Respir Cell Mol Biol 41:484–493
  Article CAS PubMed Google Scholar
• Mueller EE, Momen A, Masse S, Zhou YQ, Liu J, Backx PH, Henkelman RM, Nanthakumar K, Stewart DJ, Husain M (2011) Electrical remodelling precedes heart failure in an endothelin-1-induced model of cardiomyopathy. Cardiovasc Res 89:623–633
  Article CAS PubMed Google Scholar
• Ammarguellat F, Larouche I, Schiffrin EL (2001) Myocardial fibrosis in DOCA-salt hypertensive rats: effect of endothelin ET(A) receptor antagonism. Circulation 103:319–324
  Article CAS PubMed Google Scholar
• Mulder P, Richard V, Derumeaux G, Hogie M, Henry JP, Lallemand F, Compagnon P, Mace B, Comoy E, Letac B, Thuillez C (1997) Role of endogenous endothelin in chronic heart failure: effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling. Circulation 96:1976–1982
  Article CAS PubMed Google Scholar
• Zymek P, Bujak M, Chatila K, Cieslak A, Thakker G, Entman ML, Frangogiannis NG (2006) The role of platelet-derived growth factor signaling in healing myocardial infarcts. J Am Coll Cardiol 48:2315–2323
  Article CAS PubMed Google Scholar
• Simm A, Nestler M, Hoppe V (1998) Mitogenic effect of PDGF-AA on cardiac fibroblasts. Basic Res Cardiol 93(Suppl 3):40–43
  Article CAS PubMed Google Scholar
• Tuuminen R, Nykanen AI, Krebs R, Soronen J, Pajusola K, Keranen MA, Koskinen PK, Alitalo K, Lemstrom KB (2009) PDGF-A, -C, and -D but not PDGF-B increase TGF-beta1 and chronic rejection in rat cardiac allografts. Arterioscler Thromb Vasc Biol 29:691–698
  Article CAS PubMed Google Scholar
• Lee WW, Marinelli B, van der Laan AM, Sena BF, Gorbatov R, Leuschner F, Dutta P, Iwamoto Y, Ueno T, Begieneman MP et al (2012) PET/MRI of inflammation in myocardial infarction. J Am Coll Cardiol 59:153–163
  Article CAS PubMed Central PubMed Google Scholar
• Chen W, Frangogiannis NG (2013) Fibroblasts in post-infarction inflammation and cardiac repair. Biochim Biophys Acta 1833:945–953
  Article CAS PubMed Google Scholar
• Dobaczewski M, de Haan JJ, Frangogiannis NG (2012) The extracellular matrix modulates fibroblast phenotype and function in the infarcted myocardium. J Cardiovasc Transl Res 5:837–847
  Article PubMed Central PubMed Google Scholar
• Cannon RO 3rd, Butany JW, McManus BM, Speir E, Kravitz AB, Bolli R, Ferrans VJ (1983) Early degradation of collagen after acute myocardial infarction in the rat. Am J Cardiol 52:390–395
  Article CAS PubMed Google Scholar
• Whittaker P, Boughner DR, Kloner RA (1991) Role of collagen in acute myocardial infarct expansion. Circulation 84:2123–2134
  Article CAS PubMed Google Scholar
• Huebener P, Abou-Khamis T, Zymek P, Bujak M, Ying X, Chatila K, Haudek S, Thakker G, Frangogiannis NG (2008) CD44 is critically involved in infarct healing by regulating the inflammatory and fibrotic response. J Immunol 180:2625–2633
  CAS PubMed Google Scholar
• Corbett SA, Schwarzbauer JE (1998) Fibronectin-fibrin cross-linking: a regulator of cell behavior. Trends Cardiovasc Med 8:357–362
  Article CAS PubMed Google Scholar
• Chen W, Saxena A, Li N, Sun J, Gupta A, Lee DW, Tian Q, Dobaczewski M, Frangogiannis NG (2012) Endogenous IRAK-M attenuates postinfarction remodeling through effects on macrophages and fibroblasts. Arterioscler Thromb Vasc Biol 32:2598–2608
  Article CAS PubMed Central PubMed Google Scholar
• Creemers E, Cleutjens J, Smits J, Heymans S, Moons L, Collen D, Daemen M, Carmeliet P (2000) Disruption of the plasminogen gene in mice abolishes wound healing after myocardial infarction. Am J Pathol 156:1865–1873
  Article CAS PubMed Google Scholar
• Brown LF, Dubin D, Lavigne L, Logan B, Dvorak HF, Van de Water L (1993) Macrophages and fibroblasts express embryonic fibronectins during cutaneous wound healing. Am J Pathol 142:793–801
  CAS PubMed Google Scholar
• Gabbiani G (2003) The myofibroblast in wound healing and fibrocontractive diseases. J Pathol 200:500–503
  Article CAS PubMed Google Scholar
• Lerman RH, Apstein CS, Kagan HM, Osmers EL, Chichester CO, Vogel WM, Connelly CM, Steffee WP (1983) Myocardial healing and repair after experimental infarction in the rabbit. Circ Res 53:378–388
  Article CAS PubMed Google Scholar
• Holmes JW, Borg TK, Covell JW (2005) Structure and mechanics of healing myocardial infarcts. Annu Rev Biomed Eng 7:223–253
  Article CAS PubMed Google Scholar
• Ren G, Michael LH, Entman ML, Frangogiannis NG (2002) Morphological characteristics of the microvasculature in healing myocardial infarcts. J Histochem Cytochem 50:71–79
  Article CAS PubMed Google Scholar
• Xia Y, Lee K, Li N, Corbett D, Mendoza L, Frangogiannis NG (2009) Characterization of the inflammatory and fibrotic response in a mouse model of cardiac pressure overload. Histochem Cell Biol 131:471–481
  Article CAS PubMed Google Scholar
• Nicoletti A, Heudes D, Mandet C, Hinglais N, Bariety J, Michel JB (1996) Inflammatory cells and myocardial fibrosis: spatial and temporal distribution in renovascular hypertensive rats. Cardiovasc Res 32:1096–1107
  Article CAS PubMed Google Scholar
• Schellings MW, Pinto YM, Heymans S (2004) Matricellular proteins in the heart: possible role during stress and remodeling. Cardiovasc Res 64:24–31
  Article CAS PubMed Google Scholar
• Zheng J, Chen Y, Pat B, Dell’italia LA, Tillson M, Dillon AR, Powell PC, Shi K, Shah N, Denney T et al (2009) Microarray identifies extensive downregulation of noncollagen extracellular matrix and profibrotic growth factor genes in chronic isolated mitral regurgitation in the dog. Circulation 119:2086–2095
  Article CAS PubMed Central PubMed Google Scholar
• Nagatomo Y, Carabello BA, Coker ML, McDermott PJ, Nemoto S, Hamawaki M, Spinale FG (2000) Differential effects of pressure or volume overload on myocardial MMP levels and inhibitory control. Am J Physiol Heart Circ Physiol 278:H151–H161
  CAS PubMed Google Scholar
• Janicki JS, Brower GL, Gardner JD, Forman MF, Stewart JA Jr, Murray DB, Chancey AL (2006) Cardiac mast cell regulation of matrix metalloproteinase-related ventricular remodeling in chronic pressure or volume overload. Cardiovasc Res 69:657–665
  Article CAS PubMed Google Scholar
• Biernacka A, Frangogiannis NG (2011) Aging and cardiac fibrosis. Aging Dis 2:158–173
  PubMed Central PubMed Google Scholar
• Robert V, Besse S, Sabri A, Silvestre JS, Assayag P, Nguyen VT, Swynghedauw B, Delcayre C (1997) Differential regulation of matrix metalloproteinases associated with aging and hypertension in the rat heart. Lab Invest 76:729–738
  CAS PubMed Google Scholar
• Chen W, Frangogiannis NG (2010) The role of inflammatory and fibrogenic pathways in heart failure associated with aging. Heart Fail Rev 15:415–422
  Article CAS PubMed Central PubMed Google Scholar
• Bujak M, Kweon HJ, Chatila K, Li N, Taffet G, Frangogiannis NG (2008) Aging-related defects are associated with adverse cardiac remodeling in a mouse model of reperfused myocardial infarction. J Am Coll Cardiol 51:1384–1392
  Article PubMed Central PubMed Google Scholar
• Brilla CG, Matsubara L, Weber KT (1996) Advanced hypertensive heart disease in spontaneously hypertensive rats. Lisinopril-mediated regression of myocardial fibrosis. Hypertension 28:269–275
  Article CAS PubMed Google Scholar
• Brilla CG, Funck RC, Rupp H (2000) Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease. Circulation 102:1388–1393
  Article CAS PubMed Google Scholar
• Berry JM, Le V, Rotter D, Battiprolu PK, Grinsfelder B, Tannous P, Burchfield JS, Czubryt M, Backs J, Olson EN et al (2011) Reversibility of adverse, calcineurin-dependent cardiac remodeling. Circ Res 109:407–417
  Article CAS PubMed Central PubMed Google Scholar
• Patel R, Nagueh SF, Tsybouleva N, Abdellatif M, Lutucuta S, Kopelen HA, Quinones MA, Zoghbi WA, Entman ML, Roberts R, Marian AJ (2001) Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy. Circulation 104:317–324
  Article CAS PubMed Central PubMed Google Scholar
• Lim DS, Lutucuta S, Bachireddy P, Youker K, Evans A, Entman M, Roberts R, Marian AJ (2001) Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy. Circulation 103:789–791
  Article CAS PubMed Central PubMed Google Scholar
• Weidemann F, Herrmann S, Stork S, Niemann M, Frantz S, Lange V, Beer M, Gattenlohner S, Voelker W, Ertl G, Strotmann JM (2009) Impact of myocardial fibrosis in patients with symptomatic severe aortic stenosis. Circulation 120:577–584
  Article CAS PubMed Google Scholar